Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366236434> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W4366236434 endingPage "614" @default.
- W4366236434 startingPage "612" @default.
- W4366236434 abstract "Medications for opioid use disorder (MOUDs) like buprenorphine are a first-line treatment for individuals who have opioid use disorder (OUD); however, these medications are not designed to impact the use of other classes of drugs. This descriptive study provides up-to-date information about nonopioid substance use among patients who recently initiated office-based buprenorphine treatment for OUD using data from 2 ongoing clinical trials.The study sample was composed of 257 patients from 6 federally qualified health centers in the mid-Atlantic region who recently (i.e., within the past 28 days) initiated office-based buprenorphine treatment between July 2020 and May 2022. After the screening and informed consent processes, participants completed a urine drug screen and psychosocial interview as a part of the study baseline assessment. Descriptive analyses were performed on urine drug screen results to identify the prevalence and types of substances detected.More than half of participants provided urine specimens that were positive for nonopioid substances, with marijuana (37%, n = 95), cocaine (22%, n = 56), and benzodiazepines (11%, n = 28) detected with the highest frequencies.A significant number of participants used nonopioid substances after initiating buprenorphine treatment, suggesting that some patients receiving MOUDs could potentially benefit from adjunctive psychosocial treatment and supports to address their nonopioid substance use." @default.
- W4366236434 created "2023-04-20" @default.
- W4366236434 creator A5008226908 @default.
- W4366236434 creator A5010289775 @default.
- W4366236434 creator A5014550063 @default.
- W4366236434 creator A5018852648 @default.
- W4366236434 creator A5031564001 @default.
- W4366236434 creator A5082572062 @default.
- W4366236434 date "2023-04-18" @default.
- W4366236434 modified "2023-10-07" @default.
- W4366236434 title "Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment" @default.
- W4366236434 cites W1883074425 @default.
- W4366236434 cites W2000312218 @default.
- W4366236434 cites W2315302680 @default.
- W4366236434 cites W2404633355 @default.
- W4366236434 cites W2512705875 @default.
- W4366236434 cites W2761775871 @default.
- W4366236434 cites W2887321850 @default.
- W4366236434 cites W2990459606 @default.
- W4366236434 cites W3005454586 @default.
- W4366236434 doi "https://doi.org/10.1097/adm.0000000000001168" @default.
- W4366236434 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37788620" @default.
- W4366236434 hasPublicationYear "2023" @default.
- W4366236434 type Work @default.
- W4366236434 citedByCount "0" @default.
- W4366236434 crossrefType "journal-article" @default.
- W4366236434 hasAuthorship W4366236434A5008226908 @default.
- W4366236434 hasAuthorship W4366236434A5010289775 @default.
- W4366236434 hasAuthorship W4366236434A5014550063 @default.
- W4366236434 hasAuthorship W4366236434A5018852648 @default.
- W4366236434 hasAuthorship W4366236434A5031564001 @default.
- W4366236434 hasAuthorship W4366236434A5082572062 @default.
- W4366236434 hasConcept C118552586 @default.
- W4366236434 hasConcept C126322002 @default.
- W4366236434 hasConcept C150966472 @default.
- W4366236434 hasConcept C170493617 @default.
- W4366236434 hasConcept C2778767360 @default.
- W4366236434 hasConcept C2778949969 @default.
- W4366236434 hasConcept C2779418921 @default.
- W4366236434 hasConcept C2780026642 @default.
- W4366236434 hasConcept C2780035454 @default.
- W4366236434 hasConcept C2781063702 @default.
- W4366236434 hasConcept C2909451232 @default.
- W4366236434 hasConcept C40010229 @default.
- W4366236434 hasConcept C512399662 @default.
- W4366236434 hasConcept C71924100 @default.
- W4366236434 hasConceptScore W4366236434C118552586 @default.
- W4366236434 hasConceptScore W4366236434C126322002 @default.
- W4366236434 hasConceptScore W4366236434C150966472 @default.
- W4366236434 hasConceptScore W4366236434C170493617 @default.
- W4366236434 hasConceptScore W4366236434C2778767360 @default.
- W4366236434 hasConceptScore W4366236434C2778949969 @default.
- W4366236434 hasConceptScore W4366236434C2779418921 @default.
- W4366236434 hasConceptScore W4366236434C2780026642 @default.
- W4366236434 hasConceptScore W4366236434C2780035454 @default.
- W4366236434 hasConceptScore W4366236434C2781063702 @default.
- W4366236434 hasConceptScore W4366236434C2909451232 @default.
- W4366236434 hasConceptScore W4366236434C40010229 @default.
- W4366236434 hasConceptScore W4366236434C512399662 @default.
- W4366236434 hasConceptScore W4366236434C71924100 @default.
- W4366236434 hasIssue "5" @default.
- W4366236434 hasLocation W43662364341 @default.
- W4366236434 hasLocation W43662364342 @default.
- W4366236434 hasOpenAccess W4366236434 @default.
- W4366236434 hasPrimaryLocation W43662364341 @default.
- W4366236434 hasRelatedWork W1124332915 @default.
- W4366236434 hasRelatedWork W1995144212 @default.
- W4366236434 hasRelatedWork W2003884991 @default.
- W4366236434 hasRelatedWork W2898142040 @default.
- W4366236434 hasRelatedWork W2899266174 @default.
- W4366236434 hasRelatedWork W3183150022 @default.
- W4366236434 hasRelatedWork W4281481314 @default.
- W4366236434 hasRelatedWork W4377966838 @default.
- W4366236434 hasRelatedWork W4385737324 @default.
- W4366236434 hasRelatedWork W4386084945 @default.
- W4366236434 hasVolume "17" @default.
- W4366236434 isParatext "false" @default.
- W4366236434 isRetracted "false" @default.
- W4366236434 workType "article" @default.